By expenditures
| Name | Title | Type |
|---|---|---|
| Dayna Gladstein | Chief Executive Officer | Auditee |
| Matthew Hutt | Partner | Auditee |
| Jason Dana Costa | Chief Executive Officer | Auditee |
| James Lacroix | Partner | Auditee |
| James Matzdorff | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 365599 | 2024 | 2025-09-04 | Cohnreznick LLP | $8.08M |
| 301623 | 2023 | 2024-04-01 | Cohnreznick LLP | $6.37M |
| 50262 | 2022 | 2023-02-28 | Aafcpas INC | $5.88M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 365599 | 2024 | 2025-09-04 | 1152075 | 2024-003 | Significant Deficiency | - | C |
| 365599 | 2024 | 2025-09-04 | 1152074 | 2024-002 | Significant Deficiency | - | I |
| 365599 | 2024 | 2025-09-04 | 1152073 | 2024-003 | Significant Deficiency | - | C |
| 365599 | 2024 | 2025-09-04 | 1152072 | 2024-002 | Significant Deficiency | - | I |
| 365599 | 2024 | 2025-09-04 | 1152071 | 2024-003 | Significant Deficiency | - | C |
| 365599 | 2024 | 2025-09-04 | 1152070 | 2024-002 | Significant Deficiency | - | I |
| 365599 | 2024 | 2025-09-04 | 575633 | 2024-003 | Significant Deficiency | - | C |
| 365599 | 2024 | 2025-09-04 | 575632 | 2024-002 | Significant Deficiency | - | I |
| 365599 | 2024 | 2025-09-04 | 575631 | 2024-003 | Significant Deficiency | - | C |
| 365599 | 2024 | 2025-09-04 | 575630 | 2024-002 | Significant Deficiency | - | I |
| 365599 | 2024 | 2025-09-04 | 575629 | 2024-003 | Significant Deficiency | - | C |
| 365599 | 2024 | 2025-09-04 | 575628 | 2024-002 | Significant Deficiency | - | I |
| 301623 | 2023 | 2024-04-01 | 967464 | 2023-001 | Significant Deficiency | - | L |
| 301623 | 2023 | 2024-04-01 | 967463 | 2023-001 | Significant Deficiency | - | L |
| 301623 | 2023 | 2024-04-01 | 967462 | 2023-001 | Significant Deficiency | - | L |
| 301623 | 2023 | 2024-04-01 | 967461 | 2023-001 | Significant Deficiency | - | L |
| 301623 | 2023 | 2024-04-01 | 391022 | 2023-001 | Significant Deficiency | - | L |
| 301623 | 2023 | 2024-04-01 | 391021 | 2023-001 | Significant Deficiency | - | L |
| 301623 | 2023 | 2024-04-01 | 391020 | 2023-001 | Significant Deficiency | - | L |
| 301623 | 2023 | 2024-04-01 | 391019 | 2023-001 | Significant Deficiency | - | L |